GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. Their first product, the Galleri® multi-cancer early detection test, complements guideline-recommended screenings, and can detect a cancer signal across more than 50 types of cancer through a routine blood draw for adults with elevated risk, such as aged 50 or older. When cancer is detected, the Galleri test can predict the cancer signal origin.
Note: Neither the providers nor their products or services have been reviewed, tested or screened by the International Foundation. You should exercise caution and due diligence to ascertain the appropriateness, quality and value of the products and services for their intended purpose and the financial stability of the affected provider. The International Foundation does not endorse, sponsor or promote any of the products or services offered by the providers in the Service Provider Directory.
Reserve Your Ad Space
Fill out the form below to receive pricing and more information.
GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. Their first product, the Galleri® multi-cancer early detection test, complements guideline-recommended screenings, and can detect a cancer signal across more than 50 types of cancer through a routine blood draw for adults with elevated risk, such as aged 50 or older. When cancer is detected, the Galleri test can predict the cancer signal origin.
